智通财经APP获悉，周一，德克萨斯州的一名联邦法官否决了强生公司(JNJ.US)第三次试图让其创建的子公司宣布破产，以解决数万起指控该公司滑石粉导致癌症的诉讼。该提议旨在终止指控其婴儿爽身粉和其他滑石粉产品导致卵巢癌的诉讼，即这是该公司破产策略第三次 ...

Johnson & Johnson (NYSE:JNJ) said that its acquisition of Intra-Cellular Therapies is expected to be completed on or around ...

Johnson & Johnson JNJ and Pfizer PFE are two of the world’s largest pharmaceutical companies with diversified healthcare ...

Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar ...

强生公司曾声称，该计划得到了83%的索赔人的支持，高于美国破产法规定的75%的要求，以解决数万起指控该公司滑石粉导致癌症的诉讼。根据该计划，子公司Red River Talc将宣布破产，然后获得约90亿美元的资金来支付索赔人，而不是通过法律诉讼。

Johnson & Johnson (JNJ) reports a Phase 3 success for its anti-inflammatory drug Tremfya in treating psoriatic arthritis.

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

American pharmaceutical giant Johnson & Johnson (JNJ) has once again faced rejection on its $10 billion plan to settle thousands of ...

Johnson & Johnson JNJ and Pfizer PFE are two of the world’s largest pharmaceutical companies with diversified healthcare portfolios. J&J operates through pharmaceuticals and medical devices ...

Instead of appealing, JNJ said it would return to the tort system to litigate the cases. The company is holding a conference ...